I think we are saying basically the same thing. When I referred to Insmed's "ability to manufacture" Iplex, of course that includes relevant patents, knowledge, physical plant, etc.
So if a takeover were to occur (assuming Iplex proves to be effective in trials) at what stock price, or what sp range, do you folks think they might sellout at? I realize this is just your best guesstimate. Also, what timeframe are we looking at?
News 
Market Data 
Discover 
AI
